- Live market news
- Stocks
- HIMS
Hims Hers Health Inc
HIMSStockUSA
Hims Hers Health Inc
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
Key figures
- Previous close
- 30.64
- Open
- 29.83
- Day range
- 29.68 – 29.83
- 52-week range
- —
- Volume
- 9.76M
Latest news on HIMSranked by Oyticker for market impact
- 35Impact
HIMS securities fraud lawsuit opportunity announced
A law firm is soliciting lead plaintiffs for a securities fraud class action against Hims & Hers Health, Inc., indicating potential investor claims regarding undisclosed material misstatements or omissions.
HIMSHealthcare TechnologyTelehealth - 35Impact
HIMS securities fraud lawsuit opportunity announced
A law firm is soliciting lead plaintiffs for a securities fraud class action against Hims & Hers Health, Inc., indicating potential investor claims regarding material misstatements or omissions.
HIMSHealthcare TechnologyTelehealth - 55Impact
HIMS class-action lawsuit deadline November 2, 2026; allegations of false/misleading statements
A securities class action against Hims & Hers Health alleges false or misleading investor disclosures by company and executives. The deadline for investors with substantial losses to join as lead plaintiffs is November 2, 2026.
HIMSHealthcareTelehealth - 25Impact
HIMS class-action lawsuit solicitation following stock decline
A law firm is soliciting investors with losses in HIMS following an alleged stock plunge tied to misleading financial statements. No new factual disclosure about HIMS operations, guidance or regulatory action is present.
HIMSHealthcare ServicesDigital Health - 72Impact
HIMS securities fraud class action filed; stock down >14% on privacy and billing allegations
A securities fraud class action has been initiated against Hims & Hers Health alleging deceptive privacy and billing practices, coinciding with a >14% stock decline. The lawsuit creates litigation risk and potential financial/reputational exposure for the company.
HIMSHealthcare ServicesTelehealthDigital Health - 62Impact
HIMS under investigation for alleged customer data sharing with ad platforms
Law firm Robbins LLP is investigating allegations that Hims & Hers Health shared protected customer information with advertising platforms, potentially exposing stockholders to litigation risk and regulatory exposure.
HIMSHealthcare TechnologyTelehealthDigital Health - 45Impact
Securities class action filed against HIMS; investor period Aug 2025–Jul 2026
Law firm Kaplan Fox has initiated a securities class action against Hims & Hers Health covering a 12-month investor window. The action signals potential disclosure or conduct violations during that period, though specific allegations are not detailed in this notice.
HIMSHealthcareTelehealthPharmaceuticals - 35Impact
HIMS securities fraud lawsuit opportunity announced
A law firm is soliciting lead plaintiffs for a securities fraud class action against Hims & Hers Health, Inc., indicating alleged material misstatements or omissions in disclosures.
HIMSHealthcareTelehealth
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 29.83
- Prev. close
- 30.64
Risk · 1 year
Seasonality
What HIMS filed
- 9 Nov 2026
- 9 Nov 2026
- 9 Nov 2026
Other event
- 7 Oct 2026
- 10 Aug 2026
- 10 Aug 2026
- 17 Jul 2026
- 1 Jul 2026
New debt or obligation
- 15 Jun 2026
- 2 Jun 2026
New debt or obligation · Other event
- 21 May 2026
New debt or obligation · Unregistered share sale
- 19 May 2026
- 11 May 2026
- 11 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.